Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19

Clinical trial NCT06649227 · RECRUITING

Trial details

NCT number: NCT06649227
Sponsor: University Hospital, Lille
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Adult AML

Start date: 2025-07-10
Primary completion: 2029-07-10
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.